Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine wound infiltration for analgesia after lumbar spine surgery
IRCT20210213050348N2Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Sep 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, triple-blind trial of bupivacaine and epinephrine in postoperative pain (3 arms), sponsored by Alborz University of Medical Sciences. Primary endpoint: Visual Analogue Scale score for pain at the surgical site. Started Sep 2021; status: completed.
02
Drugs
bupivacaineepinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20210213050348N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210213050348N2.